SCHEMBL3547378

SCHEMBL3547378

COc1cc(C(=O)O)cc(-c2ccccc2)c1OC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPMT P51580 2/20 0.58
TUBB4A P04350 11/20 0.54
TUBB P07437 11/20 0.54
TUBA3C P0DPH7 11/20 0.54
TUBA1B P68363 11/20 0.54
TUBA4A P68366 11/20 0.54
TUBB4B P68371 11/20 0.54
TUBB3 Q13509 11/20 0.54
TUBB2A Q13885 11/20 0.54
TUBB8 Q3ZCM7 11/20 0.54
TUBA3E Q6PEY2 11/20 0.54
TUBA1A Q71U36 11/20 0.54
TUBA1C Q9BQE3 11/20 0.54
TUBB6 Q9BUF5 11/20 0.54
TUBB2B Q9BVA1 11/20 0.54
TUBB1 Q9H4B7 11/20 0.54
PKM P14618 2/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
CA12 O43570 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6735457 0.90 PDE4B (0.51) TPMTTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL17655663 0.86 TPMT (0.70) TPMTPKMKMT2ACA12CA1
SCHEMBL3647091 0.84 IKBKB (0.50) TPMTTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6735793 0.84 TTR (0.49) TPMTTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL21941471 0.83 TPMT (0.59) TPMTMEN1KMT2AHTTALDH1A1
SCHEMBL21942061 0.83 ACLY (0.49) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL21941912 0.83 CA12 (0.50) TPMTTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL21941913 0.83 CA12 (0.50) TPMTTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL29034612 0.81 MEN1 (0.53) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
3,4,5-Trimethoxybenzoic Acid SCHEMBL6592 0.80 TPMT (0.78) TPMTTUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691843-B2 N-hydroxyamide derivatives possessing antibacterial activity PFIZER INC. (US) 2010-04-06 US disclosed
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity VICURON HOLDINGS LLC 2008-03-06 US disclosed
EP-1539744-A4 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARM INC (US) 2007-06-06 EP disclosed
EP-1539744-A2 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2005-06-15 EP disclosed
WO-2004007444-A2 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS, INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity AMDHD2, OGA, ENGASE TPMT 3495/4885TUBB4A 909/4885TUBB 517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.